research use only

Pipobroman DNA alkylator modulator

Cat.No.S4447

Pipobroman (PB, Vercyte), a neutral amide of piperazine, acts as an alkylating agent with antiproliferative activity.
Pipobroman DNA alkylator modulator Chemical Structure

Chemical Structure

Molecular Weight: 356.05

Quality Control

Batch: S444701 DMSO]71 mg/mL]false]Ethanol]71 mg/mL]false]Water]Insoluble]false Purity: 99.58%
99.58

Chemical Information, Storage & Stability

Molecular Weight 356.05 Formula

C10H16Br2N2O2

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 54-91-1 -- Storage of Stock Solutions

Synonyms PB, Vercyte Smiles BrCCC(=O)N1CCN(CC1)C(=O)CCBr

Solubility

In vitro
Batch:

DMSO : 71 mg/mL ( (199.41 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 71 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06367374 Not yet recruiting
Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma
Institute of Hematology & Blood Diseases Hospital China
May 30 2024 Phase 2
NCT05791409 Recruiting
CLL/SLL
Stichting Hemato-Oncologie voor Volwassenen Nederland|Nordic CLL Study Group|German CLL Study Group
April 10 2024 Phase 1|Phase 2
NCT06080256 Not yet recruiting
Intracranial Atherosclerosis|Atherosclerotic Plaque|Stenosis
The First Affiliated Hospital with Nanjing Medical University
December 30 2023 Phase 3

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.